Thomas L Holland

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Monoclonal Antibody

Community Acquired Pneumonia

End Stage Renal Disease

Top Venues

PharmacoEconomics

The Journal of antimicrobial chemotherapy

The New England journal of medicine

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ahmad Mourad, Alison G Smith, Jesse D Troy, Thomas L Holland, Rebekah H Wrenn, Nicholas A Turner
Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Ahmad Mourad, Alison G Smith, Jesse D Troy, Thomas L Holland, Rebekah H Wrenn, Nicholas A Turner
Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics 42 (9) (2024)
Andrew John Sutton, Daniel S Lupu, Stephen P Bergin, Thomas L Holland, Staci A McAdams, Sanjeet Singh Dadwal, Khoi Nguyen, Frederick S Nolte, Gabriel Tremblay, Bradley A Perkins
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia. PharmacoEconomics (2024)
Ahmad Mourad, Alison G Smith, Jesse D Troy, Thomas L Holland, Rebekah H Wrenn, Nicholas A Turner
Clinical outcomes in patients with piperacillin/ tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection. The Journal of antimicrobial chemotherapy (2024)
Stephen P Bergin, Roy F Chemaly, Sanjeet S Dadwal, Joshua A Hill, Yeon Joo Lee, Ghady Haidar, Alfred Luk, Alexander Drelick, Peter V Chin-Hong, Esther Benamu, Fareed Khawaja, Deepa Nanayakkara, Genovefa A Papanicolaou, Catherine Butkus Small, Monica Fung, Michelle A Barron, Thomas Davis, Micah T McClain, Eileen K Maziarz, Deng B Madut, Armando D Bedoya, Daniel L Gilstrap, Jamie L Todd, Christina E Barkauskas, Robert Bigelow, Jeffrey D Leimberger, Ephraim L Tsalik, Olivia Wolf, Mona Mughar, Desiree Hollemon, Radha Duttagupta, Daniel S Lupu, Sivan Bercovici, Bradley A Perkins, Timothy A Blauwkamp, Vance G Fowler, Thomas L Holland
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients with Pneumonia: A Prospective Observational Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Thomas L Holland, Sara E Cosgrove, Sarah B Doernberg, Timothy C Jenkins, Nicholas A Turner, Helen W Boucher, Oleksander Pavlov, Ivan Titov, Serhii Kosulnykov, Boyko Atanasov, Ivan Poromanski, Manana Makhviladze, Anastasia Anderzhanova, Martin E Stryjewski, Maziar Assadi Gehr, Marc Engelhardt, Kamal A Hamed, Daniel Ionescu, Mark Jones, Mikael Saulay, Jennifer Smart, Harald Seifert, Vance G Fowler, null null
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia. The New England journal of medicine (2023)
Nicholas A Turner, Smitha Zaharoff, Heather King, Scott Evans, Toshimitsu Hamasaki, Thomas Lodise, Varduhi Ghazaryan, Tatiana Beresnev, Todd Riccobene, Rinal Patel, Sarah B Doernberg, Urania Rappo, Vance G Fowler, Thomas L Holland, null null
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial. Trials 23 (1) (2022)
null null, Jens Dilling Lundgren, Birgit Grund, Christina E Barkauskas, Thomas L Holland, Robert L Gottlieb, Uriel Sandkovsky, Samuel M Brown, Kirk U Knowlton, Wesley H Self, D Clark Files, Mamta K Jain, Thomas Lars Benfield, Michael E Bowdish, Bradley G Leshnower, Jason V Baker, Jens-Ulrik Stæhr Jensen, Edward M Gardner, Adit A Ginde, Estelle S Harris, Isik Somuncu Johansen, Norman Markowitz, Michael A Matthay, Lars Østergaard, Christina C Chang, Anna L Goodman, Weizhong Chang, Robin L Dewar, Norman P Gerry, Elizabeth S Higgs, Helene Highbarger, Daniel D Murray, Thomas A Murray, Ven Natarajan, Roger Paredes, Mahesh K B Parmar, Andrew N Phillips, Cavan S Reilly, Adam W Rupert, Shweta Sharma, Kathryn Shaw-Saliba, Brad T Sherman, Marc Teitelbaum, Deborah Wentworth, Huyen Cao, Paul Klekotka, Abdel G Babiker, Victoria J Davey, Annetine C Gelijns, Virginia L Kan, Mark N Polizzotto, Boyd Taylor Thompson, Henry Clifford Lane, James D Neaton
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial. Annals of internal medicine 175 (2) (2021)